Scudiero DA - Search Results

1

Substituted purine analogues define a novel structural class of catalytic topoisomerase II inhibitors.

Jensen LH, Thougaard AV, Grauslund M, Søkilde B, Carstensen EV, Dvinge HK, Scudiero DA, Jensen PB, Shoemaker RH, Sehested M. Jensen LH, et al. Among authors: scudiero da. Cancer Res. 2005 Aug 15;65(16):7470-7. doi: 10.1158/0008-5472.CAN-05-0707. Cancer Res. 2005. PMID: 16103101

2

Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway.

Rapisarda A, Uranchimeg B, Scudiero DA, Selby M, Sausville EA, Shoemaker RH, Melillo G. Rapisarda A, et al. Among authors: scudiero da. Cancer Res. 2002 Aug 1;62(15):4316-24. Cancer Res. 2002. PMID: 12154035

3

Application of high-throughput, molecular-targeted screening to anticancer drug discovery.

Shoemaker RH, Scudiero DA, Melillo G, Currens MJ, Monks AP, Rabow AA, Covell DG, Sausville EA. Shoemaker RH, et al. Among authors: scudiero da. Curr Top Med Chem. 2002 Mar;2(3):229-46. doi: 10.2174/1568026023394317. Curr Top Med Chem. 2002. PMID: 11944818 Review.

4

Identification of a new natural camptothecin analogue in targeted screening for HIF-1alpha inhibitors.

Klausmeyer P, McCloud TG, Melillo G, Scudiero DA, Cardellina JH 2nd, Shoemaker RH. Klausmeyer P, et al. Among authors: scudiero da. Planta Med. 2007 Jan;73(1):49-52. doi: 10.1055/s-2006-951767. Planta Med. 2007. PMID: 17315309

5

Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay.

Alley MC, Scudiero DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL, Abbott BJ, Mayo JG, Shoemaker RH, Boyd MR. Alley MC, et al. Among authors: scudiero da. Cancer Res. 1988 Feb 1;48(3):589-601. Cancer Res. 1988. PMID: 3335022

6

Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines.

Scudiero DA, Shoemaker RH, Paull KD, Monks A, Tierney S, Nofziger TH, Currens MJ, Seniff D, Boyd MR. Scudiero DA, et al. Cancer Res. 1988 Sep 1;48(17):4827-33. Cancer Res. 1988. PMID: 3409223

7

Imidazo[2,1-b]thiazole guanylhydrazones as RSK2 inhibitors.

Andreani A, Granaiola M, Leoni A, Locatelli A, Morigi R, Rambaldi M, Varoli L, Lannigan D, Smith J, Scudiero D, Kondapaka S, Shoemaker RH. Andreani A, et al. Eur J Med Chem. 2011 Sep;46(9):4311-23. doi: 10.1016/j.ejmech.2011.07.001. Epub 2011 Jul 8. Eur J Med Chem. 2011. PMID: 21794960

8

Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.

Sack U, Walther W, Scudiero D, Selby M, Kobelt D, Lemm M, Fichtner I, Schlag PM, Shoemaker RH, Stein U. Sack U, et al. J Natl Cancer Inst. 2011 Jul 6;103(13):1018-36. doi: 10.1093/jnci/djr190. Epub 2011 Jun 17. J Natl Cancer Inst. 2011. PMID: 21685359

9

Homology model of RSK2 N-terminal kinase domain, structure-based identification of novel RSK2 inhibitors, and preliminary common pharmacophore.

Nguyen TL, Gussio R, Smith JA, Lannigan DA, Hecht SM, Scudiero DA, Shoemaker RH, Zaharevitz DW. Nguyen TL, et al. Among authors: scudiero da. Bioorg Med Chem. 2006 Sep 1;14(17):6097-105. doi: 10.1016/j.bmc.2006.05.001. Epub 2006 May 24. Bioorg Med Chem. 2006. PMID: 16723234

10

Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines.

Rubinstein LV, Shoemaker RH, Paull KD, Simon RM, Tosini S, Skehan P, Scudiero DA, Monks A, Boyd MR. Rubinstein LV, et al. Among authors: scudiero da. J Natl Cancer Inst. 1990 Jul 4;82(13):1113-8. doi: 10.1093/jnci/82.13.1113. J Natl Cancer Inst. 1990. PMID: 2359137

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

89 results

Search Page

Filters